Spectrum Advisory Services’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
$1.44M Sell
22,239
-111
-0.5% -$7.55K 0.57% 64
2015
Q4
$1.72M Hold
22,350
0.69% 55
2015
Q3
$1.84M Sell
22,350
-112
-0.5% -$9.97K 0.76% 49
2015
Q2
$1.98M Sell
22,462
-558
-2% -$51.2K 0.75% 50
2015
Q1
$2.03M Buy
23,020
+419
+2% +$37.2K 0.72% 49
2014
Q4
$1.88M Hold
22,601
0.65% 52
2014
Q3
$1.91M Hold
22,601
0.69% 51
2014
Q2
$1.83M Sell
22,601
-112
-0.5% -$8.81K 0.63% 52
2014
Q1
$1.73M Hold
22,713
0.62% 55
2013
Q4
$1.64M Sell
22,713
-196
-0.9% -$13.6K 0.58% 58
2013
Q3
$1.57M Sell
22,909
-223
-1% -$14.8K 0.61% 55
2013
Q2
$1.47M Buy
+23,132
New +$1.51M 0.59% 57

Other funds holding NVS

Spectrum Advisory Services's NVS Position: Q1 2016 in Review

Spectrum Advisory Services reduced its Novartis (NVS) stake by 0.5% in Q1 2016, selling an estimated $7.55K and leaving 22,239 shares worth $1.44M. The position accounts for 0.57% of the portfolio, ranked #64.

Spectrum Advisory Services first reported a position in NVS in Q2 2013 and has held it in 12 quarters since. The position peaked at $2.03M in Q1 2015. 875 funds tracked by Wall St. Rank hold NVS as of Q1 2016.

  • Spectrum Advisory Services held 22,239 shares of Novartis worth $1.44M as of Q1 2016.
  • Spectrum Advisory Services sold 111 Novartis shares in Q1 2016, an estimated $7.55K.
  • Novartis made up 0.57% of Spectrum Advisory Services's portfolio in Q1 2016, its #64 holding.
  • Spectrum Advisory Services first reported a position in Novartis in Q2 2013 and has held it in 12 quarters since.
  • Spectrum Advisory Services's Novartis position peaked at $2.03M in Q1 2015.
  • 875 funds tracked by Wall St. Rank held Novartis as of Q1 2016.

Based on Spectrum Advisory Services's 13F filing for Q1 2016, filed 12 May 2016.